STSS
Sharps Technology, Inc.NASDAQHealthcare$1.51-7.36%ClosedMarket Cap: $43.8M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.14
P/S
214.50
EV/EBITDA
-0.12
DCF Value
$0.50
FCF Yield
-25.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
-202.5%
Operating Margin
-132145.5%
Net Margin
-138400.0%
ROE
-156.5%
ROA
-105.0%
ROIC
-4075.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $-2.3M | $-182.7M | $-49.03 |
| FY 2025 | $204.1K | $-282.5M | $-11.16 |
| Q3 2025 | $2.3M | $-105.3M | $-4.33 |
| Q2 2025 | $222.7K | $3.6M | $3.58 |
Trading Activity
Insider Trades
View AllFalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
2.20
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.